Paper15857504
In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line.
Hoffmeyer MR and 2 others. Cancer Cell Int, 2005. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line. Papers, record 15857504. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15857504
- Cell line
- SUM149PT75 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R21CA083957 | NIH |
Source NIH RePORTER
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10887484 | Human breast cancer cell lines as models of growth regulation and disease progression. | J Mammary Gland Biol Neoplasia | 1996 | https://conductscience.org/library/papers/10887484 | PubMed |
| 2 | 10537277 | A novel human xenograft model of inflammatory breast cancer. | Cancer Res | 1999 | https://conductscience.org/library/papers/10537277 | PubMed |
| 3 | 11353057 | Persistent E-cadherin expression in inflammatory breast cancer. | Mod Pathol | 2001 | https://conductscience.org/library/papers/11353057 | PubMed |
| 4 | 9472046 | CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. | J Cell Biol | 1998 | https://conductscience.org/library/papers/9472046 | PubMed |
| 5 | 10952316 | Genomic analysis of metastasis reveals an essential role for RhoC. | Nature | 2000 | https://conductscience.org/library/papers/10952316 | PubMed |
| 6 | 12808121 | Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. | Lab Invest | 2003 | https://conductscience.org/library/papers/12808121 | PubMed |
| 7 | 11082269 | Rho GTPases: signaling, migration, and invasion. | Exp Cell Res | 2000 | https://conductscience.org/library/papers/11082269 | PubMed |
| 8 | 8610272 | Inflammatory breast cancer. | Surg Clin North Am | 1996 | https://conductscience.org/library/papers/8610272 | PubMed |
| 9 | 12530938 | The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. | Curr Hypertens Rep | 2003 | https://conductscience.org/library/papers/12530938 | PubMed |
| 10 | 11809710 | Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. | Cancer Res | 2002 | https://conductscience.org/library/papers/11809710 | PubMed |
| 11 | 10375527 | Interplay between Rac and Rho in the control of substrate contact dynamics. | Curr Biol | 1999 | https://conductscience.org/library/papers/10375527 | PubMed |
| 12 | 12032865 | Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. | Oncogene | 2002 | https://conductscience.org/library/papers/12032865 | PubMed |
| 13 | 10648558 | RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism. | J Cell Biol | 2000 | https://conductscience.org/library/papers/10648558 | PubMed |
| 14 | 9930872 | An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. | Nat Med | 1999 | https://conductscience.org/library/papers/9930872 | PubMed |
| 15 | 9459160 | Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9459160 | PubMed |
| 16 | 11128990 | Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton. | Philos Trans R Soc Lond B Biol Sci | 2000 | https://conductscience.org/library/papers/11128990 | PubMed |
| 17 | 12618881 | Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12618881 | PubMed |
| 18 | 12718869 | Closing the GAP: a role for a RhoA GAP in cytokinesis. | Mol Cell | 2003 | https://conductscience.org/library/papers/12718869 | PubMed |
| 19 | 3856043 | Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. | J Natl Cancer Inst | 1985 | https://conductscience.org/library/papers/3856043 | PubMed |
| 20 | 12361600 | Actin cable dynamics and Rho/Rock orchestrate a polarized cytoskeletal architecture in the early steps of assembling a stratified epithelium. | Dev Cell | 2002 | https://conductscience.org/library/papers/12361600 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42748134 | From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells. | PLoS One | 2026 | https://conductscience.org/library/papers/42748134 | PubMed |
| 40366255 | E-Cadherin Is a Structuring Component of Invadopodia in Pancreatic Cancer. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40366255 | PubMed |
| 36902125 | Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902125 | PubMed |
| 35155241 | Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells. | Front Oncol | 2022 | https://conductscience.org/library/papers/35155241 | PubMed |
| 32648934 | In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer. | Biotechnol Bioeng | 2020 | https://conductscience.org/library/papers/32648934 | PubMed |
| 29671772 | Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29671772 | PubMed |
| 28965853 | Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells. | Cancer Lett | 2017 | https://conductscience.org/library/papers/28965853 | PubMed |
| 28758107 | Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer. | Medicines (Basel) | 2017 | https://conductscience.org/library/papers/28758107 | PubMed |
| 28460441 | Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies. | Oncotarget | 2017 | https://conductscience.org/library/papers/28460441 | PubMed |
| 28009978 | The secretion and biological function of tumor suppressor maspin as an exosome cargo protein. | Oncotarget | 2017 | https://conductscience.org/library/papers/28009978 | PubMed |
| 26958085 | Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression. | J Cancer | 2016 | https://conductscience.org/library/papers/26958085 | PubMed |
| 26404901 | Microfluidic cytometric analysis of cancer cell transportability and invasiveness. | Sci Rep | 2015 | https://conductscience.org/library/papers/26404901 | PubMed |
| 25701047 | COX-2 dependent regulation of mechanotransduction in human breast cancer cells. | Cancer Biol Ther | 2015 | https://conductscience.org/library/papers/25701047 | PubMed |
| 25184143 | E-cadherin and gastric cancer: cause, consequence, and applications. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25184143 | PubMed |
| 24291763 | Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. | Int J Biochem Cell Biol | 2014 | https://conductscience.org/library/papers/24291763 | PubMed |
| 23689139 | Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization. | Cancer Lett | 2013 | https://conductscience.org/library/papers/23689139 | PubMed |
| 23386909 | In Vitro Assessment of the Inflammatory Breast Cancer Cell Line SUM 149: Discovery of 2 Single Nucleotide Polymorphisms in the RNase L Gene. | J Cancer | 2013 | https://conductscience.org/library/papers/23386909 | PubMed |
| 23320987 | TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity. | J Hematol Oncol | 2013 | https://conductscience.org/library/papers/23320987 | PubMed |
| 22937154 | Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. | PLoS One | 2012 | https://conductscience.org/library/papers/22937154 | PubMed |
| 22440943 | E-cadherin's dark side: possible role in tumor progression. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/22440943 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15857504
GET https://conductscience.org/api/papers/v1/15857504/references?page=2